# UCSF BP Activate Letter Study

> **NCT06152094** · NA · COMPLETED · sponsor: **University of California, San Francisco** · enrollment: 484 (actual)

## Conditions studied

- Hypertension

## Interventions

- **OTHER:** BP Activate Letter
- **OTHER:** Control Letter

## Key facts

- **NCT ID:** NCT06152094
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-07-20
- **Primary completion:** 2024-12-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 484 (ACTUAL)
- **Last updated:** 2025-01-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06152094

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06152094, "UCSF BP Activate Letter Study". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT06152094. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*